Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:29 PM
Ignite Modification Date:
2025-12-24 @ 3:29 PM
NCT ID:
NCT00519792
Eligibility Criteria:
Inclusion Criteria:
* Chronic Hepatitis C with HCV genotype 1 infection
* Relapse following an end of treatment response after treatment with a pegylated interferon and ribavirin.
Exclusion Criteria:
* Presence or history of non-HCV chronic liver disease
* Treatment with any interferon subsequent to the relapse with pegylated interferon-alpha and ribavirin
* Decompensated liver disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00519792
Study Brief:
Protocol Section:
NCT00519792